A landmark study in 2012 showed that a mutation in a TBX5 RE was associated with a case of isolated congenital heart disease, atypical for TBX5 loss-of-function mutations and Holt–Oram syndrome [95]. This evidence concerns the gene TBX5 and congenital heart disease.